CheckMyRecalls

10,013 recalls · updated 20 Nov 2026

Ajanta Pharma USA Inc recalls Ranolazine Extended-Release Tablets

Read the official FDA notice

Published
7 Oct 2026
Agency
FDA
Country
United States

The hazard

Failed Dissolution Specifications: below specification

Classification: Class II — this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.

What to do

Do not stop a prescribed medicine without talking to your doctor or pharmacist first. Ask them about a replacement, and return the recalled product to the pharmacy.

  • Check the lot number on the box or bottle.
  • Talk to your pharmacist or doctor before stopping any prescribed medicine.
  • Return the product to the pharmacy for safe disposal.
Read the official FDA notice

Product details

Ranolazine Extended-Release Tablets, 1000 mg, 60-count bottle, Rx Only, Marketed by: Ajanta Pharma USA Inc., Bridgewater, NJ 08807. NDC: 27241-126-02

Brand / company
Ajanta Pharma USA Inc
Codes / lots
Lot: DJ25134, Exp 11/30/2028
Distribution
Nationwide in the US.
Recall status
Ongoing

Source: U.S. Food and Drug Administration, published 7 Oct 2026. CheckMyRecalls reproduces the official notice in summary; always confirm the details with the original notice.